Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MavriX Bio, launched in 2024 through FAST’s AS²Bio accelerator, is a biotechnology company focused exclusively on Angelman syndrome. Built on pioneering research from Dr. Jim Wilson’s lab at the University of Pennsylvania (now GEMMABio), MavriX aims to advance the first investigational gene replacement therapy for this rare neurogenetic disorder. With strong leadership and strategic guidance from AS²Bio, MavriX is commit...
    MavriX Bio, launched in 2024 through FAST’s AS²Bio accelerator, is a biotechnology company focused exclusively on Angelman syndrome. Built on pioneering research from Dr. Jim Wilson’s lab at the University of Pennsylvania (now GEMMABio), MavriX aims to advance the first investigational gene replacement therapy for this rare neurogenetic disorder. With strong leadership and strategic guidance from AS²Bio, MavriX is committed to translating scientific innovation into meaningful clinical progress.

    List your booth number for exhibitions, ask us

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.